Analysts expect that Hydrogenics Co. (NASDAQ:HYGS) (TSE:HYG) will announce sales of $11.65 million for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Hydrogenics’ earnings. The lowest sales estimate is $10.00 million and the highest is $13.30 million. Hydrogenics reported sales of $7.67 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 51.9%. The firm is expected to report its next quarterly earnings results on Friday, November 1st.
According to Zacks, analysts expect that Hydrogenics will report full year sales of $44.75 million for the current year, with estimates ranging from $39.50 million to $50.00 million. For the next fiscal year, analysts forecast that the firm will report sales of $90.20 million. Zacks’ sales calculations are an average based on a survey of sell-side research firms that follow Hydrogenics.
Hydrogenics (NASDAQ:HYGS) (TSE:HYG) last announced its earnings results on Monday, August 12th. The energy company reported ($0.25) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.13). The company had revenue of $10.46 million during the quarter, compared to the consensus estimate of $10.50 million. Hydrogenics had a negative return on equity of 78.06% and a negative net margin of 38.16%.
A number of large investors have recently modified their holdings of the business. NJ State Employees Deferred Compensation Plan increased its stake in Hydrogenics by 11.1% in the first quarter. NJ State Employees Deferred Compensation Plan now owns 40,000 shares of the energy company’s stock valued at $317,000 after purchasing an additional 4,000 shares in the last quarter. Morgan Stanley increased its stake in Hydrogenics by 31.5% in the second quarter. Morgan Stanley now owns 40,412 shares of the energy company’s stock valued at $600,000 after purchasing an additional 9,677 shares in the last quarter. Ancora Advisors LLC bought a new stake in Hydrogenics in the second quarter valued at approximately $297,000. Gamco Investors INC. ET AL bought a new stake in Hydrogenics in the second quarter valued at approximately $309,000. Finally, GABELLI & Co INVESTMENT ADVISERS INC. bought a new stake in Hydrogenics in the second quarter valued at approximately $325,000. 11.09% of the stock is owned by hedge funds and other institutional investors.
Shares of HYGS traded up $0.02 on Thursday, reaching $14.96. 224,500 shares of the company’s stock were exchanged, compared to its average volume of 140,881. The stock has a market capitalization of $284.13 million, a P/E ratio of -17.40 and a beta of 0.63. The business has a 50 day moving average price of $14.92 and a two-hundred day moving average price of $10.43. Hydrogenics has a 12 month low of $3.80 and a 12 month high of $16.50.
Hydrogenics Company Profile
Hydrogenics Corporation, together with its subsidiaries, designs, develops, and manufactures hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane (PEM) technology. It operates through two segments, OnSite Generation and Power Systems.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Hydrogenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hydrogenics and related companies with MarketBeat.com's FREE daily email newsletter.